微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 28.86% | 23.95% | 4.46% | 34/52 | 36.36% | 百奥赛图 | 74.91% | 行业排名> |
| 2025-06-30 | 27.63% | 46.8% | 4.92% | 39/52 | 36.49% | 百奥赛图 | 74.39% | 行业排名> |
| 2025-03-31 | 26.33% | 66.21% | 7.08% | 39/52 | 34.34% | *ST生物 | 64.96% | 行业排名> |
| 2024-12-31 | 24.59% | -39.57% | 5.62% | 40/52 | 35.25% | 百奥赛图 | 77.67% | 行业排名> |
| 2024-09-30 | 23.28% | -49.39% | 23.72% | 42/52 | 35.76% | *ST生物 | 68.03% | 行业排名> |
| 2024-06-30 | 18.82% | -59.96% | 18.79% | 45/52 | 36.65% | 百奥赛图 | 74.42% | 行业排名> |
| 2024-03-31 | 15.84% | -68.46% | -61.07% | 44/52 | 35.74% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 40.69% | -21.69% | -11.55% | 27/52 | 38.77% | 百奥赛图 | 70.59% | 行业排名> |
| 2023-09-30 | 46% | -12.48% | -2.11% | 14/52 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 46.99% | -10.26% | -6.44% | 12/52 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 50.23% | 2.62% | -3.34% | 6/52 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 51.96% | 25.63% | -1.14% | 7/52 | 40.75% | 百奥赛图 | 73.38% | 行业排名> |
| 2022-09-30 | 52.56% | 20.25% | 0.37% | 7/52 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 52.36% | 21.84% | 6.99% | 7/52 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 48.94% | 21.17% | 18.33% | 11/52 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 41.36% | -0.76% | -5.37% | 29/52 | 42.48% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 43.71% | 5.21% | 1.7% | 23/52 | 43.07% | *ST生物 | 84.53% | 行业排名> |
| 2021-06-30 | 42.98% | 11.36% | 6.41% | 26/52 | 42.6% | *ST生物 | 83.19% | 行业排名> |
| 2021-03-31 | 40.39% | 6.46% | -3.09% | 18/52 | 39.47% | *ST生物 | 83.9% | 行业排名> |
| 2020-12-31 | 41.68% | 10.14% | 0.32% | 28/52 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 41.55% | 10.7% | 7.64% | 18/52 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 38.6% | 3.9% | 1.73% | 23/52 | 39.28% | *ST生物 | 78.74% | 行业排名> |
| 2020-03-31 | 37.94% | 19.52% | 0.26% | 14/52 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 37.84% | 13.08% | 0.83% | 36/52 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 37.53% | 10.75% | 1.02% | 21/52 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 37.15% | 6.28% | 17.03% | 23/52 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 31.74% | -6.48% | -5.14% | 24/52 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 33.46% | -8.93% | -1.25% | 37/52 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 33.89% | -14.7% | -3.06% | 21/52 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 34.95% | -9.5% | 2.98% | 25/52 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 33.94% | -14.13% | -7.62% | 22/52 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 36.74% | -7.36% | -7.51% | 26/52 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 39.73% | 5.66% | 2.85% | 18/52 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 38.62% | -6.33% | -2.3% | 20/52 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 39.53% | -1.44% | -0.33% | 13/52 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 39.66% | 21.82% | 5.49% | 17/52 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 37.6% | 19.59% | -8.81% | 12/52 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 41.23% | 41.24% | 2.8% | 10/52 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 40.11% | 35.74% | 23.19% | 9/52 | 28.42% | 盈康生命 | 75.69% | 行业排名> |